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         Synthetic chemistry plays a key role in drug discovery. Finding a simple method to prepare 
drug candidates is the important to synthetic chemists. However, approaching drug molecules by 
traditional methods needs several steps which give a low yielding and time-consuming process. 
To rapidly approach target drug molecule, chemists now use C-H functionalization as a powerful 
tool to modify small molecules. Radical mediated C-H functionalization is currently a hot topic 
in synthetic chemistry due to its mild and highly selective properties. Besides C-H activation, 
radical mediated C-O activation also allow scientists to modify drug cores which cannot be 
reached previously. Herein, I report three related projects I joined during the two-year 
undergraduate researches in Nagib lab. The first one is polarity-reversal cascade for C-H 
functionalization of heteroarenes. In this project, quinoline and its derivatives are functionalized 
via a umpolung strategy. During the summer, to approach the cheap and effective catalyst, I tried 
to accomplish coupling reaction between olefins and aldehydes by photo-induced iron catalyst. 
The last one is silver-catalyzed decarboxylative fluorination of alcohol. An additive-based 
robustness screening is done to check the functional group compatibility in this project. 
 
General Introduction 
        Every year there are many new drugs being invented and to be approved by FDA. In 2017, 
totally 44 types of novel drug were approved by FDA and already 9 drugs were approved in 
2018 till now1,2.  Organic chemistry is considered as one of the main drivers in drug discovery 
process3. New techniques developed help synthetic chemists and medicinal chemists to better 
utilize organic chemistry for synthesis3. Normally drug molecules are complex and needs 
synthetic chemists to find a way to synthesize. In traditional method, to synthesize a complex 
molecule, multiple steps are required, including addition of other functional group precursor and 
protection of functional group, which are usually troublesome and cause the low yielding. For 
example, paclitaxel total synthesis by Norton group was a 46-steps procedure and the overall 
yield was very low4. These limitations cause the high cost to pharmaceutical company and then 
influence the final price of these medicines that people cannot afford. Nowadays, with the 
development of organic chemistry in specific areas, this limitation is going to be broken. 
 
Figure 1: Benzodiazapine, a common drug molecule which needs several steps to synthesize 
 
        Radical chemistry has been developed for a long time. The most well-known one is 
halogenation of alkanes under light condition. Different from common thoughts, radicals are 
usually mild and highly selective. To generate a radical, there are several methods, including 
generation and homolysis of a weak bond and photocatalysis. 
        The stability of a radical depends on its electronegativity and position. Oxygen-center 
radical and nitrogen-center radical are generally unstable due to their high electronegativity5. 
Harnessing these less stable radicals, more stable radicals can be prepared. A less stable radical 
can be generated via forming and homolyzing a weak bond5. In Hofmann-Löffler-Freytag 
reaction, a weak N-Cl bond is formed and homolyze under light or heat condition5. This unstable 
radical can abstract hydrogen atom in specific position, usually 1,5-hydrogen atom transfer or 
1,5-HAT because of the stable 6-member ring intermediate, to generate a more stable carbon 
center radical. Then this new radical can trap other radicals or trapped by radical traps to access 
the target products. 
 
Figure 2: Hofmann-Löffler-Freytag Reaction5 
        Besides generating a weak bond, metal catalysts can also join to radical generation by 
oxidizing or reducing bonds via single electron transfer (SET). Excited by irradiation, some 
photocatalysts, like Ir(ppy)3 and Ru(bpy)3, enter excited state and become triplet state via metal 
to ligand charge transfer (MLCT) and rapid intersystem crossing (ISC)6. Then photocatalysts 
have both oxidant and reductant potential for redox reaction based on the situation6. Due to the 
reactivity of radicals, they can also join the C-H functionalization which is a hot topic in 
synthetic chemistry now. 
 
Figure 3: Photo-induced dehalogenation via radical pathway6 
 
        C-H bond usually is considered as a strong bond due to the high dissociation energy, which 
is around 105 kcal/mol7. The traditional methods in organic chemistry usually cannot overcome 
the energy barrier to directly activate this strong bond. In 1955, Shunshuke Murahashi reported a 
cobalt-catalyzed synthesis of phthalimidines, which was considered as very early reported C-H 
activation8. After this report, more methods for C-H functionalization were developed, including 
using metal catalyst, like iridium and rhodium, and other methods. 
 
Figure 4: Cobalt-catalyzed C-H Functionalization by Shunshuke Murahashi8 
 
         Has been developed and completed for several years, C-H functionalization now is a hot 
topic in synthetic chemistry, which is also called as Holy Grail of organic synthesis9. Many 
synthetic groups are doing C-H activation in different methods. Metal catalysts, like palladium, 
are broadly used in C-H activation by forming a metal complex intermediate with ligands. 
Ligands also play an important role in metal-catalyzed C-H activation. To activating C-H bond 
for asymmetric catalysis, the ligand should be designed as chiral. With the help of various 
ligands and metal catalysts, more C-H activation can be achieved with enantio- and chemo-
selectivity. 
 
Figure 5: Ligand for asymmetrical catalysis by Yu group10 
 
        Radical chemistry, as a major role in organic chemistry, shows its importance with more 
new reactions being developed and published. By combining radical chemistry and metal 
catalysis, C-H functionalization is also not as hard as previously. Synthetic chemistry improves 
the medicinal chemistry process and only harness all synthetic methods, more drug candidates 
will be discovered. 
        Herein, three projects I joined during the two-year undergraduate researches in Nagib lab, 




a. Polarity-Reversal Cascade for C-H functionalization of Heteroarenes 
        In medicinal chemistry, heterocycles are usually key backbones for discovering new drug 
candidates11. In 2010, more than 80% of top small molecule drugs have at least one 
heterocycles11. Acting as bioisosteres for many drug candidates, heterocycles with a variety of 
spatial structure and physicochemical properties provides a large scope for optimization of drug 
candidates11. Hydrogen bonding, lipophilicity, polarity and other factors give heterocycles a key 
role in design of pharmaceutical molecules11. 
 
 
Figure 6: Drug Containing Heterocycles11 
 
        Quinoline, as a commercial available heteroarene, exists in many drug molecules, including 
Quinine the most famous anti-malarial drug12. Besides Quinine, chloroquine, pamaquine and 
quinacrine etc. are all good anti-malarial drug containing quinoline12. Other quinoline containing 
drugs have broad effects, including anti-inflammatory, antibacterial antiviral effects13. Due to the 
wild usage in medicinal chemistry and commercial accessibility, functionalizing quinoline can 
allow medicinal chemists to find more potential drug molecules. 
 
Figure 7: Drug Molecules Containing Quinoline Core 
 
        Minisci reported a reaction in 1971 (Figure 8), which allow chemist to functionalize 
quinoline. Under acid condition, 2-methylquinoline is protonation and more electron-deficient14. 
Methanol is oxidized to generate an α-oxy radical, which is nucleophilic due to the electron-
donating conjugation effect of oxygen14. Then this radical couples with protonated quinoline in 
position 2, which is more electron-deficient position14. Following the deprotonation and 
oxidation steps, the target molecule is generated14. 
 
 
Figure 8: Minisci Reaction and Proposed Mechanism14 
 
        Minisci reaction allows chemist to rapid access the quinoline core to discover the more drug 
candidates. However, due to the electron and polarity properties, protonated quinoline can only 
accept nucleophilic radicals but not electrophilic radicals, which are not polarity matches. By 
working with Jeremy Lear and Quentin Buquoi, we reported a three-component Minisci reaction 
which uses polarity-reversal strategy to allow us to access electrophilic radical in quinoline core. 
 
Figure 9: Three-component Minisci Reaction 
 
Figure 10: Proposed Mechanism of the Reaction 
        (Diacetoxyiodo)benzene (PIDA) reacts with trimethyl azide (TMSN3) to generate a weak I-
N3 bond, which the dissociation energy is around 38 kcal/mol7. I-N bond then homolyze and an 
azide radical is generated. Ethyl vinyl ether, as a strong radical trap, then rapidly traps azide 
radical to generate a new radical. Azide radical is an electrophilic radical while the new 
generated radical is a nucleophilic radical, because of the conjugation effect of oxygen, and 
during this procedure, the polarity of the radical is reversed. 
        Polymerization happens in this reaction as a side reaction. To minimize this side reaction, 
we used multi-addition method, in which TMSN3, PIDA and ethyl vinyl ether are added in 




Figure 11: Partial Substrate Table  
 
         The substrate table for the reaction includes several quinoline derivatives which show the 
strong functional group compatibility and could have potentials in discovering more drug 
candidates. Three substrates were characterized by me, and the yields were up to 90%. Also, 
these substrates include quinoline and isoquinoline core to prove that this method can also be 
applied in other heteroarenes.  
 
Figure 12: Post-functionalization of Product 
 
         Also, to further approach the drug candidates, post-functionalization is tested. Reacting 
with triphenylphosphine and water, the azide group is reduced to amine group by Staudinger 
reaction, then the product react benzoyl chloride catalyzed by DMAP to approach amide group, 
which is also an important functional group in medicinal chemistry.  
         In step 1, triphenylphosphine attacks the azide group to from a N-P bond, with a positive 
charge on phosphine atom. Then N with negative charge attacks P to form a four-member ring 
intermediate. Nitrogen gas then leaves and a new N=P bond forms following the addition of 
water and release of triphenylphosphine oxide to form the amine product. 
 
Figure 13: Mechanism for Step 1 
 
         Herein, we reported a novel three-component Minisci reaction with polarity-reversal 
strategy to allow us to utilize electrophilic radical to functionalize quinoline core; also, post-
functionalization reaction also prove that the further reaction in drug discovery.  
 
b. Iron-Catalyzed Coupling Reaction with Aldehyde and Olefin 
         Metal-catalyzed cross coupling reactions are commonly used in organic synthesis. Suzuki-
Miyaura coupling and Buchwald-Hartwig amination are the most commonly used in medicinal 
chemistry to construct C-C and C-N bonds while other coupling reactions are also used15. 
However, for these reactions, the metal catalysts are normally palladium, or other expensive 
metals, which restrict their usage due to the high price. Discovering cheap and effective metal 
catalyst then becomes a hot topic for synthetic chemists.  
 
Figure 14: η5-cyclopentadienyliron dicarbonyl dimer 
 
         Iron is a cheap metal and its applications in coupling reactions, in which iron catalysts are 
used to construct C-C bond and C-heteroatom bonds, has been wildly reported16. η5-
cyclopentadienyliron dicarbonyl anion, or Fp anion, is a strong nucleophile17. Due to its unique 
properties, Fp anion is used to do the substitution reactions, including Fe-C bond formation and 
Fe-metal bond formation17. Also, addition reactions of Fp anion with electrophiles are also 
reported17. 
 
Table 1: Reactivity of Metalates with Organohalides17 
 
          Mankad group reported a palladium-free heck coupling between benzyl chloride and 
styrene by Fp anion under photochemical condition in 201418. The proposed mechanism is 
shown as a photoinduced alkene-insertion pathway18. Based on their report, a C-Fe bond forms 
during the reaction, following CO dissociation under UV condition and alkene insertion18. 
NaOtBu then does elimination to complete the catalyst cycle18. 
 
Figure 15: Reported Reaction by Mankad Group 
 
 
Figure 16: Proposed Mechanism Reported by Mankad Group18 
          Based on the discovery of Mankad group, we proposed that Fp anion could also be used in 
other coupling reactions. Aldehydes are important series of chemicals that are wildly used in 
industrial and pharmaceutical area. Carbonyl groups have advanced reactivity due to the polarity 
difference between carbon and oxygen, in which carbon in carbonyl group shows electrophilic 
while the oxygen shows nucleophilic. However, forming a C-C bond between aldehyde and an 
electron deficient molecule is hard due to the polarity mismatch. Umpolung strategy is used in this 
condition; benzoin condensation and Cannizzaro reaction are two well-known reactions based on 
this strategy. By increasing the acidity of the hydrogen on carbonyl group, a carbon-center anion 
is generated and then it can attack the electron deficient carbon to construct a C-C bond between 
two electron-deficient carbon. We proposed if Fp anion can be used to do the coupling reaction 
between aldehyde and olefin with umpolung strategy. 
 
Figure 17: Proposed Reaction 
 
Figure 18: Proposed Mechanism  
 
          The proposed mechanism is shown in figure 18. Fp anion, acting as a strong nucleophile, 
attacks aldehyde to form a metal complex. Under light condition, CO dissociation and alkene 
insertion happen based on the report from Mankad group. The product is generated and Fp anion 
is reproduced by basic elimination. 
          Starting from reproducing Mankad’s reaction condition, however, I couldn’t repeat the 
reaction with reported yield. In Mankad’s report, the reaction goes through a silica plug 
following sequence wash with diethyl ether18. However, Fp anion could not be removed in my 
situation so the NMR spectra for reactions were disturbed. Then by pre-addition of silica in 
reaction and washing with hexane, remaining Fp salt was mostly removed and the internal 
standard, mesitylene, was used to measure the NMR yield of the reaction. However, the repeated 
reactions could not reach the yield as high as reported yield. 
         The project was then moved on. Each step of the reaction should be proved separately. The 
addition of Fp anion to aldehyde, which was proposed as the first step, was proved by quenching 
the reaction with acid to break C-Fe bond, following the purification with silica plug and the 
NMR technique. However, the next step, which should be the C-C bond formation, didn’t work 
when I used the same condition as Mankad group reported, so I started the optimization step. 
          Several solvents, including dichloromethane, tetrahydrofuran, diethyl ether and toluene, 
were degassed by freeze pump thaw and used as solvent. However, no product was observed 
when I used different solvents. Different aldehydes were also screened. However, due to the side 
reaction between strong base and aldehyde with α-hydrogen, aldehydes without α-hydrogen 
were accessible for the reaction but still no target molecule was observed. 
          Then I assumed the olefin might play the key role in the reaction since alkene insertion is 
required for further C-C bond formation. I then used 2-propenenitrile since it is more electron-
deficient and might be better in alkene insertion step. When 2-propenenitrile was used as the 
olefin substrate, 2-(benzyloxy)acetonitrile was isolated due to the strong nucleophilicity of new 
generated alkoxide intermediate. Acyl chloride then was used in reaction to block the alkoxide 
region to prevent the further side reactions. However, the target molecule was still not observed. 
 
Figure 19: New Strategy to Block Alkoxide and Use of New Olefins 
 
            Also, I supposed the accessibility of aldehyde and tried to use different substrates to 
replace aldehydes. Benzoyl chloride and 2-bromoacetophenone were used to test the reaction. 
Constructing a Csp2 and Csp3. 
 
Figure 20: Other Substrates for Proposed reaction 
            Due to the inaccessibility of the tests, this project is temporary paused, and I move to the 
other reactions. 
c. Silver-Catalyzed Decarboxylative Fluorination of Alcohol 
        Fluorine chemistry is a broad area and plays a dramatic role in medicinal chemistry. During 
the drug design, equipping with fluorine could change the properties of the drug molecule19. Due 
to the high polarity of fluorine, the pka of a molecule can be dramatically changed when 
equipped with a fluorine; also, fluorine-containing drug molecules have very different logP 
value, which represent the solubility ratio between organic phase and aqueous phase, to target 
different active sites20. The 18F isotope can also be used as biological probe which is applied to 
study the structure in human body19. 
 
Figure 21: Some Fluorine-Containing Drug Molecule19 
 
        However, fluorination of organic molecules is usually tough since strong and dangerous 
fluorine sources are used, including F2 and HF
21. To find a mild method to construct C-F bond is 
also the target for synthetic chemists. 
        Alcohols are very common chemicals and most of them are commercial available and 
cheap. Several groups reported their discovery of fluorination of alcohols. However, most of 
these methods require fluoride as the fluorine source, including DAST or PyFlour, which are 
usually hard to handle or very sensitive22,23.  
        By working with Dr. Zuxiao Zhang, we reported a novel and mild way to do the 
fluorination of alcohol by silver catalyst. Then the robustness screening was tested to check the 
compatibility of reaction with other functional groups. 
 
Figure 22: Reaction strategy of Fluorination 
 
        Alcohols are pre-activated before the reaction. The pre-activation step is easy to handle and 
gives quantitative yield. Selectfluor was screened as the best fluorine cation source, while 
acetonitrile and 50 ℃ were found as the best solvent and reaction temperature. The substrate 
scope was broad and the yield of the standard reaction (Figure 23) could be up to 83%. 
 
Figure 23: Standard Reaction of Fluorination 
 
        The mechanism for the reaction is still not clear. Li group reported a possible mechanism in 
their decarboxylative fluorination24. Silver (I) is oxidized by SelectFluor to form a Ag-F bond 
and Ag (I) is oxidized to Ag (III). Ag (III) oxidizes substrate and is reduced to Ag (II) while a 
radical is generated via decarboxylation twice. Then the radical traps fluorine to form the final 
product while Ag (II) is reduced to Ag (I) 
 
Figure 24: Possible Mechanism 
        To prove the reactivity to be unique and novel, methods reported by other groups were used 
with our substrate24,25,26. The yields were reported as NMR yield with CF3DMAc as the internal 
standard. Ir[dF(CF3) ppy]2(dtbbpy)PF6 was used as Ir photocatalyst based on reported method. 
Acetone and acetone/water 50:50 were both used for the method from Li group. The acid form 
and the salt form of the substrates were both used based on the report from Hartwig group. Based 
on the NMR yield, reaction with methods from MacMillan group and Li group gave lower yield 
while method from Hartwig group gave trace yield. These tests prove the uniqueness and novelty 
of our reaction. 
 
Figure 25: Methods from Other Groups with Standard Substrate 
 
        Due to the importance of fluorination in medicinal chemistry, the compatibility of the 
reaction condition with functional groups and heterocycles should be high enough to prevent 
decomposition of drug molecules and other side reactions when this method is applied to 
discover more potential drug candidates. Additive-based robustness screening was applied for 
this target. Totally 18 different additives, including simple molecules and complex molecules 
with various functional groups and heterocycles, were added during the reaction preparation 
procedure. For each reaction, the product yield was NMR yield with CF3-DMAC as the internal 
standard, and the remaining amount of additive was measured by GC with mesitylene as internal 
standard. A calibration curve for each additive was generated by preparing three solutions of 
additive in different amount (0.04 mmol, 0.1 mmol and 0.2 mmol) with same amount of 
mesitylene (0.2 mmol) as internal standard. The ratio of integration area for standard to that for 
additive was calculated and then the calibration curve was generated, in which the amount of 
additive as x-axis and the ratio as y-axis. 
 
 
Table 2: Robustness Screening Results 
 
        From the table, the compatibility of the reaction with other functional groups are shown. 
Through comparing the NMR yields of these reactions with standard reaction. Based on the 
table, most of additives are compatible with the standard reaction condition to give similar 
yields. Reaction with phthalide gave a higher yield than standard condition, implying phthalide 
may be good for the reaction. Reactions with phenazine, estrone, thianaphthene and salicylic acid 
gave very low yields, which means the reaction is not compatible with these molecules and other 




Figure 26: Calibration Curve for Additive A 
 
        Also, the amounts of remaining additives were measured via GC or NMR. For some 
compounds, the GC method was used to determine the additive remaining with a calibration 
curve generated with different amount of additive and same amount of internal standard. 0.04 
mmol, 0.1 mmol and 0.2 mmol of additives were used and 0.2 mmol of internal standard were 
used. The trend of the ratio between additive and standard with percentage of additive will be a 
line and then the ratio from sample could be used to determine the remaining additives. 
Generally, heterocyclic compounds and some functional groups are compatible with the reaction 
condition, with minimum amount of them are consumed, showing the good potential of the 
reaction in fluorination of known drug molecules and drug candidates. 
        In this project, we reported a mild and convenient method of fluorination of alcohols, which 
is catalyzed by silver. Robustness screening is also done to check the functional group 
compatibility with standard condition of reaction, and the results showed high functional group 
and heterocycle tolerance. 
 
Conclusion 
         In the two-year lab experience, I did three projects. In the first project, polarity-reversal 
cascade for C-H functionalization of heteroarenes, I characterized three substrates and did the 
post-functionalization of one product to further approach the drug candidates. In the second 
project, I used η5-cyclopentadienyliron dicarbonyl anion, or Fp anion, to do the coupling reaction 
between aldehyde and olefin under photochemical condition and proved that this method was not 
very accessible and need more modification in the future. Robustness screening was done in the 
last project, silver-catalyzed decarboxylative fluorination of alcohol, to prove the compatibility 
of the reaction with other functional groups. 
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1H NMR (400 MHz, CDCl3) δ 8.71 (q, J=14.8 Hz, 2H), 8.59 (dd, J = 4.5, 1.6 Hz, 1H), 8.20 (m, 
1H), 7.88 (ddd, 1H), 7.77 – 7.67 (m,3), 5.37 (dd, J=4.5, 12.8 Hz, 1H), 4.07 (dd, J=13, 8.6 Hz, 
1H), 3.66-3.61 (m, 3H), 1.25 (t, J=7 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 157.4 (s), 143.2 (s), 133.4(s), 130.7 (s), 130.3 (s), 128.8 (s), 





1H NMR (400 MHz, CDCl3) δ 8.03 (ddd, J = 18.9, 8.4, 0.8 Hz, 2H), 7.71 (ddd, J = 8.4, 6.9, 1.4 
Hz, 1H), 7.61 – 7.52 (m, 1H), 7.47 (d, J = 0.7 Hz, 1H), 4.77 (dd, J = 7.8, 3.5 Hz, 1H), 3.65 – 3.57 





13C NMR (151 MHz, CDCl3) δ 157.91 (s), 143.21 (s), 135.89 (s), 134.03 (s), 127.97 (s), 127.76 





1H NMR (400 MHz, CDCl3) δ 8.35 (d, J=7.7 Hz, 1H), 8.07 (dd, J=8.4, 0.7 Hz, 1H), 7.84 – 7.77 
(m, 2H), 7.71 (ddd, J = 8.4, 6.9, 1.4 Hz, 1H), 7.62 – 7.40 (m, 5H), 6.70 (s, 1H) 5.29 (dd, J = 8.5, 
3.7 Hz, 1H), 4.26 – 4.09 (m, 1H), 3.88 – 3.77 (m, 1H), 3.88 – 3.40 (m, 1H), 3.31 (ddd, J = 13.9, 
9.2, 4.4 Hz, 1H), 2.77 (s, 3H), 1.26 (t, J = 7.0 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 167.77 (s), 158.81 (s), 148.26 (s), 145.35 (s), 134.33 (s), 131.71 
(s), 129.46 (s), 129.41 (s), 128.71 (s), 126.93 (s), 126.22 (s), 124.60 (s), 123.13 (s), 118.79 (s), 
77.22 (s), 77.16 (s), 65.45 (s), 45.90 (s), 25.55 (s), 15.42 (s). 
 
Potassium 2-((4-(benzoyloxy)butan-2-yl)oxy)-2-oxoacetate  
  
White solid, m.p = 163.1-164.4℃ 
1H NMR (600 MHz, DMSO) δ 8.00 – 7.94 (m, 2H), 7.66 (tq, J = 4.5, 1.6 Hz, 1H), 7.53 (t, J = 7.8 
Hz, 2H), 5.02 – 4.86 (m, 1H), 4.35 – 4.29 (m, 1H), 4.23 (dt, J = 11.1, 6.8 Hz, 1H), 2.02 – 1.87 
(m, 2H), 1.22 (d, J = 6.3 Hz, 3H).  
13C NMR (151 MHz, DMSO) δ 166.92 (s), 165.65 (s), 162.64 (s), 133.26 (s), 129.72 (s), 129.13 
(s), 128.71 (s), 65.76 (s), 61.34 (s), 34.48 (s), 19.91 (s). 







HRMS (ESI) calcd. For [M+Na+] 219.0792, found: 219.0791. 
1H NMR (600 MHz, CDCl3) δ 8.06 – 8.01 (m, 2H), 7.56 (t, J = 7.4 Hz, 1H), 7.44 (t, J = 7.8 Hz, 
2H), 4.97 – 4.79 (m, 1H), 4.52 – 4.37 (m, 2H), 2.15 – 1.94 (m, 2H), 1.41 (dd, J = 23.9, 6.2 Hz, 
3H).  
19F NMR (565 MHz, CDCl3) δ -175.29 – -175.64 (m).  
13C NMR (151 MHz, CDCl3) δ 166.55 (s), 133.07 (s), 130.37 (s), 129.68 (s), 128.48 (s), 87.94 
(d, J = 165.7 Hz), 61.23 (d, J = 5.4 Hz), 36.24 (d, J = 21.1 Hz), 21.19 (d, J = 22.5 Hz). 
IR (film) cm–1: 2980, 2935, 1716, 1452, 1384, 1269, 1109 
